1. Introduction {#s0005}
===============

The world is currently facing the COVID-19 pandemic with a novel corona virus, SARS-CoV-2, initially observed in Wuhan, Hubei, China in the end of 2019 ([@b0120]). The reported symptoms of COVID-19 are primarily respiratory with acute respiratory distress syndrome ultimately leading to dead in the most severe cases ([@b0095]). However, COVID-19 have also been shown to affect other organs, including the brain, and recently reports on neurological symptoms due to COVID-19 infection are emerging ([@b0105], [@b0340], [@b0085], [@b0005], [@b0295]). There are indications of neurotropic properties of SARS-CoV-2; however, yet little appears to be known about the exact mechanisms on how it affects brain functioning ([@b0360]).

COVID-19 is a betacoronavirus ([@b0245]) and knowledge from other outbreaks with viruses from the corona family, like SARS-CoV-1 ([@b0065]), can now be useful, despite differences between the viruses. Psychiatric symptoms including posttraumatic stress symptoms (PTSS)/posttraumatic stress disorder (PTSD), anxiety and depression among patients with SARS-CoV-1 have been reported during the SARS epidemic ([@b0040], [@b0050]) and after 1 month ([@b0045], [@b0390]), 1 year ([@b0190]) and 30 months and longer ([@b0255], [@b0170]). Also psychiatric symptoms of PTSD, depression and anxiety have been described among health care workers during ([@b0230]) and 2 months ([@b0365]); 2 ([@b0175]) and 3 years ([@b0235]) after the SARS epidemic as well as among the general public during ([@b0110]) and after the epidemic ([@b0140], [@b0310]).

We aimed to systematically review the literature in order to provide an overview of the psychiatric complications to COVID-19 infection (direct effect) and how COVID-19 are currently affecting mental health among psychiatric patients and general public (indirect effect) alongside with factors altering the risk of psychiatric symptoms in both groups.

2. Material and methods {#s0010}
=======================

2.1. Eligibility criteria {#s0015}
-------------------------

The following studies were included:1.Studies reporting psychiatric symptoms/morbidity of patients with current or prior SARS-CoV-2 infection.2.Studies reporting psychiatric symptoms/morbidity of psychiatric patients during the COVID-19 pandemic3.Studies measuring psychiatric symptoms/morbidity/mental health during the COVID-19 in uninfected/not known to be infected participants, divided in health care workers and non-health care workers

Papers with psychiatric symptoms/morbidity in the elderly (including dementia), children/adolescents (including Attention Deficit Hyperactivity Disorder and autism), substance abuse and somatic disease as primary outcome were not included.

2.2. Information sources {#s0020}
------------------------

Studies were identified by searching the database PubMed. Only papers published in English were included. The publication period was unlimited. The search was performed at the May 10, 2020.

2.3. Search string {#s0025}
------------------

(Psychiatry OR "mental health disorders" OR "mental health") AND (COVID-19 OR SARS-CoV-2)

2.4. Study selection {#s0030}
--------------------

One investigator (NV) screened titles and abstracts to exclude obviously irrelevant articles and further examined the remaining full text reports to determine compliance with inclusion criteria. One investigator (NV) screened relevant reviews for additional trials and NV examined full text reports of these additional records. The study selection process is illustrated in [Supplementary Fig. 1](#s0155){ref-type="sec"}.

2.5. Data collection process {#s0035}
----------------------------

The data extraction was carried out by one investigator (NV) but repeated.

2.6. Data items {#s0040}
---------------

We sought for the following information in the full-text records: journal information (authors and year of publication), study design and instruments, number of participants, demographics (sex, age, employment (health-care/non-health care)), psychiatric symptoms/morbidity, risk factors/factors associated with psychiatric symptoms/morbidity and infectious status (currently infected, previously infected, no history of infection).

3. Results {#s0045}
==========

The initial search resulted in 460 hits and additional 4 papers were identified from the references in reviews from the search. Of these 101 were included for full text review leading to inclusion of 43 papers ([Table 1](#t0005){ref-type="table"}, [Table 2](#t0010){ref-type="table"} ). Out of these, two papers evaluated patients with confirmed COVID-19 infection, and 41 the indirect effect of the pandemic (2 on patients with preexisting psychiatric disorders, 20 on medical health care workers and 19 on the general public). 18 of the studies were case-control studies or compared to norms, while 25 of the studies had no control groups.Table 1Studies of psychiatric symptoms/disorders during the COVID-19 pandemic among patients with COVID-19, psychiatric patients and health-care workers.Reference*Design* (study instruments)Partici-pantsMales (%)Mean ageCountryHealth care workersPsychiatric symptom/morbidityCOVID-19 statusMain findings*A. Patients with COVID-19*[@b0435]*Case-control*\
App-based, anonymous questionnaire\
(GAD-7, GHQ-9)20550.946.9China, GuangdongNoAnxiety, depressionInfected (n = 57)\
Quarantine (n = 50)\
Unknown (=98)Infected: increased prevalence of depression (29.2%) compared to the individuals under quarantine (p = 0.016). No difference compared to the general public.\
No difference in anxiety between groups (p = 0.154)[@b0015]*Cases only* Online survey\
(PCL-17)71449.150.2China, WuhanNoPTSSInfectedPTSS: 96.2%  *B. Psychiatric patients without unknown COVID-19 status*[@b0080]*Psychiatric patients only*329.429.2SpainNoAnxiety, worries, eating disorder symptomatologyUnknown37.5% reported impairments in their eating disorder symptomatology. 56.2% reported additional anxiety symptoms.[@b0445]*Psychiatric patients only*\
Self-report questionnaire\
(GAD-7, PHQ-9, ISI)2065n.a.n.a.China, ChengduNoAnxiety, depression, insomniaUnknown20.9% of patients with preexisting psychiatric disorders reported deterioration of their mental health due to the pandemic.\
Preexisting disorders: depression, bipolar disorders and schizophrenia (no specification of numerical distribution).  *C. Health care workers and the COVID-19 pandemic*[@b0025]*Case-control*\
Questionnaire\
(SCL-90, CD-RISC, SSRS)152124.5GroupedChina, JiangsuYesResilience, support, somatization, OCD, depression, anxiety, hostility, psychoticismUnknownPrevalence of psychological abnormality: 14.1%.\
Phobic anxiety higher among fresh staff compared to experienced staff (P = 0.017).[@b0125]*Case-control*\
Web-based survey\
(GAD-7, CES-D, PSQI)723645.435.3China, variable regionsYesAnxiety, depression, sleep qualityUnknownGeneral public: Generalized anxiety: 35.1%, depressive symptoms: 20.1% and sleep quality: 18.2%\
Increased risk of anxiety/depressive symptoms.: Age \< 35 (all p \< 0-0.001)\
Increased risk of poor sleep quality: Health care workers (p \< 0.001), but no difference in anxiety (p = 0.501) or depression (p = 0.439). No differences according to sex.[@b0200]*Case-control*\
Anonymous questionnaire\
(VTS)74021.928.0China, variable regionsYesVicarious traumatization scores (including scores for physiological and psychological responses)UnknownVTS front-line nurses (physiological and psychological responses): significantly lower than of non-front-line nurses (P \< 0.001).\
VTS general public: significantly higher than those of the front-line nurses (P \< 0.001)[@b0215]*Case-control*\
(AIS, SRQ-20)94823.4GroupedChina, Wuhan/NingboYesInsomniaUnknownHigher degree of insomnia and general psychological symptoms in Wuhan (compared to Ningbo, P = 0.001, P = 0.044).\
Risk factors of insomnia in Wuhan: females (OR = 1.38, P = 0.042), lower education (OR = 1.54, P = 0.0076) and general psychological symptoms (OR = 2.12, P \< 0.01)[@b0225]*Case-control*\
(SDS, SAS)59n.a.GroupedChinaYesDepression, anxietyUnknownNo difference in SDS or SAS among health care workers in COVID-19 department compared to cardiological department and ICU (P = 0.44, P = 0.31). No significant difference between age (over or below 30, P = 0.11, P = 0.76).[@b0250]*Case-control*\
Online questionnaire\
(NRS, HAMA, HAMD)229922.1GroupedChina, FujianYesFear, anxiety, depressionUnknownSignificant higher average level of fear (4.89, p \< 0.001), anxiety (4.73, p = 0.015) and depression (2.41, p = 0.029) among medical staff compared to administrative staff\
High-risk contact associated with increased symptoms compared to low-risk contact and non-clinical work (fear: P = 0.027, anxiety: P = 0.003, depression: P = 0.007) and high risk contact had higher ratios of fear (HR = 1.41, P = 0.034), anxiety (HR = 2.06, P = 0.001), depressive symptoms (HR = 2.02, P = 0.0023) compared to non-clinical staff[@b0405]*Case-control*\
Questionnaire\
(Anxiety scale, depressionscore, dream anxiety score and SF-36 scale)12036.736.7China, ShanghaiYesAnxiety, depression, dream anxietyUnknownSurgical staff: significant higher degree of anxiety (p \< 0.001), higher level of dream anxiety (p \< 0.001), SF-36 (p \< 0.001), and depression (p \< 0.001) during compared to surgical staff when the outbreak was under control[@b0410]*Case-control*\
Online questionnaire14,505\
(707)55.6GroupedChinaYesDifficulty to fall asleep, early wake upUnknownFrontline workers (among the medically isolated population) had higher risk of difficulties in falling asleep compared to none-health workers (OR: 1.81, 95%CI: 1.01--3.24) and of waking up early (OR: 3.13, 95%CI: 1.48--6.65)\
No difference according to age or sex.[@b0430]*Case-control*\
Online Survey\
(ISI, PHQ-4, GAD-2, PHQ-2, SCL-90-R)218235.8GroupedChinaYesInsomnia, anxiety, depression, OCD, phobic anxietyUnknownMedical health workers: higher prevalence of insomnia (38.4% vs 30.5% p \< 0.01), anxiety (13.0% vs 8.5% p \< 0.01), depression (12.2% vs 9.5% p \< 0.04), somatization (1.6 vs 0.4%, p \< 0.01), and OCD symptoms (5.3 vs 2.2%, p \< 0.01) compared to nonmedical health workers.\
Significant higher total scores among health care workers of ISI, GAD-2, PHQ-2 and SCL-90-R (p ≤ 0.01).\
Increased risk of insomnia medical health workers: living in rural areas (OR: 2.18), risk of contact to COVID-19 patients (OR: 2.53), having organic disease (OR: 3.39) (all p \< 0.001).\
Increased risk of anxiety medical health workers:\
Female (OR: 1.80) and living in rural areas (1.88) (all p = 0.002), risk of contact with COVID-19 patient and having organic disease (all p \< 0.001).\
Increased risk of depression medical health workers: female (OR: 1.85, P = 0.02), having organic disease (OR: 2.51, P \< 0.01)[@b0035]*Comp. to norm*\
Self-rated questionnaire (SDS, SAS)1059.532.6China, GuiyangYesAnxiety, depressionUnknownMean SAS and SDS scores were significantly higher than the norms (all p \< 0.001).\
Anxiety: Slight: 10.5%, moderate: 5.7%, severe: 1.9%. Depression: slight: 21.0%, moderate: 4.8%, severe: 3.8%\
No difference in anxiety and depression, but higher rates of depression accompanied by anxiety when exposure experience (P = 0.042). Not affected by sex or age.[@b0275]*Comp. to norm*\
Online questionnaire\
(SOS, SAS)18010.032.7China, GuangxiYesAnxiety, stress loadUnknownSAS scores higher compared to norm (P \< 0.001).\
Stress-load correlated positively with anxiety.[@b0395]*Comp. to norm*\
Questionnaire\
(SAS, GSES, SARS, PSQI, SRSS)18028.332.3China, variable regionsYesAnxiety, stress, self-efficacy, sleep-qualityUnknownAnxiety, stress, and self-efficacy levels depend on sleep quality and social support\
Poor sleep quality of health care workers compared to norms[@b0135]*Survey*\
Questionnaire\
(PHQ-9, GAD-7, ISI, IES-R)99414.5n.a.China, WuhanYesDepression\
Anxiety\
Insomnia\
Distress1.9% infectedSubthreshold disturbances: 36.9%, mild disturbances: 34.4%, moderate disturbances: 22.4%, severe disturbances: 6.2%\
Clustered in accordance to psychiatric scores (4 clusters); higher scores associated with infected patients, colleagues, friends, neighbor, co-residents (all p \< 0.001), own infection (P = 0.023) and family infected (P = 0.005) and self-perceived health status (\<0.001).[@b0345]*Survey*\
Anonymous online survey\
(PCL-5)209139.2GroupedChina, Variable regionsYesPTSS2.3% suspected or confirmedGeneral public PTSS prevalence: 4.6%. High risk public PTSS: 18.4% Health care workers PTSS: 4.4%.\
Positively associated with higher score (multiple linear regression): female, Hubei province, subjective poor sleep quality (all p \< 0.001). No difference according to age.[@b0055]*Survey*\
Online questionnaire\
(PHQ-9)69n.a.n.a.Hong KongYesDepressionUnknownMild depression: 34.8%\
Moderate depression: 14.5%[@b0070]*Survey*\
Smart-phone based survey\
(PSS, BDI, BAI)13439.536.0China, WuhanYesStress, depression, anxietyUnknownDepressive symptoms: 20.1%, anxiety symptoms: 12.7%\
Health care workers going to Wuhan from other regions in order to help had better sleep quality, lower perceived stress and less depressive symptoms (all Ps \< 0.05).\
Positively associated with depression and anxiety: lack of psychological preparedness, perceived self-efficacy to help the patients, family support; greater perceived stress; or having poor sleep quality. Positively associated with anxiety: Lacking knowledge, higher education attainment, and family/friends infected.[@b0165]*Survey*\
Questionnaire\
(PHQ-9, GAD-7, ISI, IES-R)125723.3GroupedChina, variable regionsYesDepression, anxiety, insomnia, and distressUnknownDepressive symptoms: 50.4%, anxiety symptoms: 44.6%, insomnia: 34.0%, distress: 71.5%\
Factors associated with significantly higher level of all outcome measures: being nurse (vs. physician, all p = 0.007, 0.008, \<0.001, 0.009), female (vs male, all p \< 0.001), frontline (vs. second line, all p \< 0.001), secondary hospital (vs. tertiary, all p \< 0.001, 0.005, 0.008, 0.46) an Wuhan (vs. outside Wuhan, all p \< 0.001)\
Increased risk of depression symptoms: female (OR = 1.94, P = 0.003), secondary hospital (OR = 1.65, P = 0.004), title intermediate (OR = 1.77 compared to junior, P = 0.005), frontline workers (OR = 1.52, P = 0.01). Increased risk of anxiety symptoms: female (OR = 1.69, P 0.001), secondary hospital (OR = 1.43, P = 0.01), title intermediate (OR = 1.82, P \< 0.001), frontline (OR = 1.57, P \< 0.001). Insomnia: frontline (OR = 2.97, P \< 0.001). Distress: female (OR = 1.45, P \< 0.01), intermediate (OR = 1.94, P \< 0.001), frontline (OR = 1.60, P \< 0.001). Decreased risk of distress: outside Hubei (OR = 0.62, P = 0.008)[@b0205]*Survey*\
Questionnaire\
(PHQ-9, GAD-7, IES-R)43690GroupedChina, WuhanYesStress, depression, anxietyUnknownDepression: 14.2%, anxiety: 25.2%, stress: 31.6%.\
Positively associated factors: \>10 years of working, with medical history (including psychiatric history and ≥ 2 children. Negatively associated: exercise habit.\
Increased risk of anxiety and depression with drinking history (OR: 1.95, P \< 0.001 and OR: 1.71, P = 0.004), depression with relatives suspected confirmed COVID-19 (OR: 1.31, P = 0.018), self being suspected/confirmed (OR: 1.93, P = 0.001). Increased risk of stress among nurses compared to medical technician (OR: 1.41, P 0.007) and family member suspected/confirmed infected (OR: 1.39, P \< 0.001)[@b0370]*Survey*\
Self-report questionnaire\
(PSQI, SAS, SDS)1231033.8China, WuhanYesSleep disturbances, depression, anxietyUnknownFactors positively associated with poor sleep: job title (doctor, P \< 0.05), frontline worker (P \< 0.001), being only child (P \< 0.01).\
Poor sleep quality was associated with higher anxiety and depression score (P \< 0.01, P \< 0.001). Not related to sex or age.\
Risk factors of sleep disturbance: being only child (vs not OR: 3.40), frontline worker (vs not OR: 2.97), depressive symptoms (vs. not OR: 2.83) (all Ps \< 0.05).[@b0425]*Survey*\
Questionnaire\
(ISI, PHQ-9, GAD-7, IES-R)156317.3n.a.ChinaYesInsomnia, depression, anxiety, stressUnknownOverall prevalence: Insomnia symptoms: 36.1%, depressive symptoms: 50.7% (PHQ-9 ≥ 5), anxiety symptoms: 44.7% (GAD-7 ≥ 5), stress symptoms: 73.4% (IES-R ≥ 9).\
Increased risk: lower educational level (OR: 2.69, P = 0.042), working in isolation unit (OR: 1.71, P = 0.038), worry about being infected (OR: 2.30, P \> 0.001), less perceived social support (OR: 2.10, P = 0.001, uncertainty of disease control (OR: 3.30, P = 0.013).\
Higher proportions of females (P = 0.003 in the insomnia group.[^1]Table 2Studies of psychiatric symptoms/disorders during the COVID-19 pandemic among the general public.Reference*Design* study instrumentsPartici-pantsMales (%)Mean ageCountryHealth care workersPsychiatric symptom/morbidityCOVID-19 statusMain findings[@b0220]*Case-control*\
Weibo posts17,86525.233China, variable regionsNoWords of emotions\
Words of concernsUnknownSignificant differences of emotional indicators prior to and after COVID-19 with increased anxiety, depression and indignation (all P \< 0.001).[@b0330]*Case-control*\
Online survey\
(WHO-5)24584949.1DenmarkNoPsychological well-beingUnknownWHO-5 mean score significantly lower than in 2016 (62.0 vs 64.3 (p \< 0.001)).\
Significantly higher proportion of female respondents with WHO-5 scores \< 50 compared to 2016 (28.8% vs. 24.6%, P = 0.005), but not among males (21.8% vs. 20.0%, P = 0.110)[@b0350]*Case-control*\
Online questionnaire (DASS-21, ISI, IES-R)67374.430.8China, ChongquingNoPTSD, anxiety, depression, stressUnknownPrevalence: PTSD: 10.8%, anxiety: 6.0%, depression: 5.9%, stress: 3.3%, insomnia: 2.3%, hallucinations: 3.1%, paranoid ideations: 2.2%, suicidal ideations: 1.6%.\
No significant difference in any items between workers/technical staff (n = 551) and management/executive staff (n = 122) (all P \> 0.05)[@b0420]*Case-control*\
Questionnaire\
(HADS, VDAS, SF-36)10043.037.0China,NoDepressive, anxiety, dream anxietyUnknownParents of children hospitalized during the epidemic period had significant higher scores of anxiety, depression and dream anxiety compared to parents of children hospitalized in the non-epidemic period (all p \< 0.001)[@b0450]*Case-control*\
App-based questionnaire\
(SRQ-20, GAD-7, PHQ-9)227940.5Groupedn.a.No (yes 37.6%)Anxiety, depression,UnknownIncreased risk of psychological (OR: 3.593), anxiety (OR: 4.686) and depression symptoms (OR: 4.313) with impacts on daily life (all p \< 0.001), but not with quarantine status between quarantine (n = 1443) and non-quarantine (n = 836) group (all p ≥ 0.303).[@b0375]*Survey (Longitudinal)*\
National University of Singapore COVID-19 questionnaire\
(IES-R, DASS-21)1738 (333)32.7GroupedChina, variable regionsNoAnxiety, depression, stressUnknownNo significant difference in anxiety, depression and stress symptoms in a with increasing number of confirmed cases compared to a period with increasing number of recovered cases (all P \> 0.05)\
Overall mean score for both measuring points \> 24 indicating presence of PTSD symptoms.\
Positively associated with stress, anxiety or depression: physical symptoms, very poor self-rating of health, and history of chronic illness (both measuring points).[@b0210]*Survey*\
Online survey\
(GHQ-12, perceived severity, BSCS)460727.523.7China, variable regionsNoMental health problems2.3% infectedParticipants with low self-control and/or higher perceived severity of COVID-19 reported more mental health problems (p \< 0.001)[@b0400]*Survey*\
Questionnaire\
(PSCI-16, SAS, SASR, PSQI)17059.437.8China, variable regionsNoAnxiety, sleep quality, distress, social capital10.6% infectedLow social capital was positively correlated with anxiety, stress and sleep quality (All p \< 0.01)[@b0030]*Survey*\
Questionnaire\
(GAD-7)714330.4n.a.China, variable regionsNoAnxietyUnknownSevere anxiety: 0.9%, moderate anxiety: 2.7%\
mild anxiety: 21.3%\
Increased risk: relative/acquaintance infected with COVID-19 (OR = 3.007, P \< 0.001)\
Decreased risk: living in urban areas (OR = 0.810, P = 0.002), steady family income (OR = 0.726, P \< 0.001), living with parents (OR = 0.752, P = 0.017)\
Negatively correlated: economic worry, academic delay worry, influence on daily life (All p \< 0.001).\
Positively correlated: social support (P \< 0.001).[@b0100]*Survey*\
Online survey\
(WHO-5, GAD-7)482732.332.3China, variable regionsNo\
(yes 5.2%)Depression, anxietyUnknownDepression prevalence: 48.3%, anxiety: 22.6%\
Increased risk of anxiety/depression: age 31--40 compared to \< 20 (OR: 1.69 95%CI: 1.07--2.68). lower educational level, lower self-rated health (OR: 1.77 95%CI: 1.41--2.21) and higher social media exposure (OR: 1.91, 95%CI: 1.52--2.41).\
Increased risk of depression: age 21--30 (OR: 1.49) compared to \< 20 and living in urban areas. Increased risk of anxiety: living in Hubei.\
No difference in sex in anxiety/depression (OR: 0.90 (95%CI: 0.77--1.05) and age (OR: 1.51, 95%CI: 1.00--2.30).[@b0280]*Survey*\
Anonymous online questionnaire\
(*K*10, TEMPS-A, ASQ)50040.4GroupedItalyNoPsychological distressUnknown62%: No likelihood of psychological distress\
19.4%: mild likelihood of psychological distress\
18.6%: moderate-severe likelihood of psychological distress\
Moderate-severe compared to no distress:\
Increased risk: cyclothymic (OR = 1.24, P \< 0.001), depressive (OR: 1.52; p \< 0.001) and anxious (OR: 1.58; p = 0.002) temperaments, need for approval (Or = 1.08, P = 0.01).\
Decreased risk: confidence (OR = 0.89, P = 0.002), discomfort with closeness (OR = 0.92, P = 0.001)\
No difference in age (OR = 1, P = 0.97) and sex (OR = 0.58, P = 0.08).[@b0240]*Survey*\
Questionnaire\
(PCL-5, PSQI)28545.6GroupedChina, HubeiNo\
(yes: 4.2%)PTSSUnknownPTSS: 7%\
Positively associated factors: female, high risk public, lower education, poor sleep quality (all p \< 0.001).[@b0270]*Survey*\
Online survey\
(DASS-21, PID-5-BF)276628.332.9ItalyNoDepression, anxiety, stressUnknownFactors associated with depressive and anxiety symptoms: female (all Ps \< 0.001), history of stress (P = 0.001, P = 0.003) and history of medical problems (all Ps \< 0.001). Factors associated with depressive symptoms: lower education (P \< 0.001), not having a child (P = 0.033), relative infected (0.006), Factors associated with anxiety symptoms: young age (P = 0.001),), infected family (P = 0.013). Factors associated with stress: young age, female (all P \< 0.001), going to work (P = 0.006), acquaintance infected (P = 0.018), history of stress (P = 0.035) and medical problems (P = 0.003).[@b0305]*Survey*\
Online survey\
(HADS, HAI)34350.737.2TurkeyNoDepression, anxietyUnknownFactors associated with depression and anxiety (P = 0.047, P \< 0.001), infected friends/relatives (P = 0.001, P = 0.014), current psychiatric illness (P = 0.020, P \< 0.001), previous psychiatric illness (P = 0.036, P = 0.011).\
Factors associated with depression: living in urban areas (compared to rural, P = 0.029) and anxiety: chronic disease (P = 0.001).\
Increased risk of depression and anxiety: female (OR: 2.48, P = 0.001), previous psychiatric history (OR = 0.363, P = 0.001), Decreased risk of depression and anxiety: urban residence (vs rural, OR = 0.36, P = 0.015, OR = 0.53, P = 0.36).[@b0315]*Survey*\
Online questionnaire\
(CPDI)52,73035.3n.a.China, Hong Kong, Taiwan, MacauNoAnxiety, depression,\
specific phobias, cognitive change, avoidance and compulsive behavior, physical symptoms\
and loss of social functioningUnknownPsychological distress: 34.4%\
Factors associated with higher psychological distress: female (24.87 vs. 21.41, P \< 0.001), age 18--30 or \> 60,\
migrant workers, middle region of China (all p \< 0.001)[@b0320]*Survey*\
Online questionnaire\
(Likert scale)66248.629.1IndiaNoAnxietyUnknown72% was worried for them self/relatives. 12% had sleep difficulties.[@b0355]*Survey*\
Online questionnaire\
(SCL-90)106051.835.0China, variable regionsNo\
(yes)Somatization,\
OCD, IS, depression, anxiety, hostility, phobica, anxiety, paranoid ideation and psychoticism.UnknownPsychological symptoms (moderate or more): 70% (OC, IS, PHOB, and PSY 4 dimensions)\
Factors associated with more symptoms: higher ages, undergraduate education and below, divorced or widowed, and agricultural workers (all p \< 0.001),\
No significant difference according to sex (P = 0.72)[@b0380]*Survey*\
Online Survey\
(IES-R, DASS-21)121032.7GroupedChina, variable regionsNoDepression, anxiety, distressUnknownExperienced psychological impact moderate-severe: 53.8%\
Moderate-severe depressive symptoms: 16.5%\
Moderate-severe anxiety symptoms: 28.8%\
Moderate-severe stress levels: 8.1%\
Factors positively associated with stress, anxiety and depression symptoms: Female gender, student status, specific physical symptoms (e.g., myalgia, dizziness, coryza),and poor self-rated health (all p \< 0.05)\
Factors negatively associated: health information, precautionary measures (all p \< 0.05).[@b0440]*Survey*\
Survey\
(SF12, K6)36955.036.6China, variable regionsNoMental health, distressUninfectedPeople working at office (P = 0.01) and people working from home (P = 0.03) had better mental health compared to people who stopped working.[^2][^3]

3.1. Patients with COVID-19 {#s0050}
---------------------------

Only two papers ([@b0015], [@b0435]) reported on psychiatric symptoms among patients with COVID-19. The first study showed that PTSS were present among 96.2% out of 714 hospitalized but stabile patients. The second study showed that the prevalence of depression (29.2%) was elevated (p = 0.016) among 57 patients newly recovered from COVID-19 compared to participants in quarantine (9.8%), while no difference in anxiety level was found (P = 0.154).

3.2. Patients with psychiatric disorders prior to and during COVID-19 {#s0055}
---------------------------------------------------------------------

One study evaluated symptoms of patients with eating disorders during the pandemic and found 37.5% to report worsening in their eating disorder symptomatology and 56.2% to report additional anxiety symptoms ([@b0080]), while another study reported that 20.9% of patients with preexisting psychiatric disorders reported worsening of their symptoms, but did not report the preexisting diagnoses ([@b0445]).

3.3. Psychiatric symptoms/psychological distress among health care workers {#s0060}
--------------------------------------------------------------------------

Among health care workers depression/depressive symptoms (six papers) and anxiety (eight papers) were increased (compared to norms ([@b0035], [@b0275]), administrative staff ([@b0250], [@b0430]), when the pandemic was under control ([@b0405]), or to experienced staff ([@b0025]), while two papers found no difference (compared to the general public ([@b0125]) and non-frontline workers ([@b0225])). Poor sleep quality was found among health care workers compared to norms ([@b0395]). No difference in PTSS was observed ([@b0345]), and Vicarious traumatization scale scores were actually less elevated (P \< 0.001) when comparing to the general public ([@b0200]). Higher levels of obsessive--compulsive disorder symptoms were reported in medical health workers compared to non-medical staff ([@b0430]).

3.4. Psychiatric symptoms/psychological distress among the general public {#s0065}
-------------------------------------------------------------------------

Regarding the general public one paper revealed lower psychological well-being (WHO-5) compared to before COVID-19 ([@b0330]), and one study revealed increased use of words as emotional indicators of anxiety and depression (on Weibo), when compared to prior to the outbreak ([@b0220]). Furthermore a study of parents of children hospitalized during the epidemic period had significant higher scores of anxiety, depression and dream anxiety compared to parents of children hospitalized in the non-epidemic period (all p \< 0.001) ([@b0420]). However, a study found no significant difference in anxiety, depression or stress symptoms when comparing scores measured in a period with increase in number of confirmed cases to a period with increase in number of recovered cases (P \> 0.05); however, only 333 of the 1210 cases were followed up ([@b0375]). One study found no significant difference in any items between workers/technical staff (n = 551) and management/executive staff (n = 122) (all P \> 0.05) ([@b0350]), and one study found no difference between being in quarantine (n = 1443) or not (n = 836) ([@b0450]).

3.5. Risk factors of anxiety and depression {#s0070}
-------------------------------------------

The following factors were reported to be associated with risk of psychiatric symptoms among health care workers and the general public:

### 3.5.1. Sociodemographic factors {#s0075}

The following sociodemographic factors were associated with depression and/or anxiety: living alone ([@b0030]), lower educational level ([@b0100], [@b0270]), but also higher ([@b0070]), student status ([@b0380]), not having a child ([@b0270]), or having ≥ 2 children ([@b0205]), living in urban areas ([@b0100], [@b0305]), but also in rural areas ([@b0430], [@b0030]), female gender ([@b0430], [@b0165], [@b0270], [@b0380], [@b0305]) was reported frequently, but was not consistent ([@b0035], [@b0100]), while reports on age as a risk factor were inconsistent ([@b0100], [@b0270], [@b0115]).

### 3.5.2. Current or past medical history {#s0080}

Current medical disease (including psychiatric disorders and substance abuse) ([@b0430], [@b0375], [@b0305]), and a past medical history (including psychiatric history and substance abuse) ([@b0375], [@b0270], [@b0205], [@b0305]) were associated with/increased the risk of depression and/or anxiety.

### 3.5.3. Psychological and social factors {#s0085}

Poor-self rated health ([@b0375], [@b0100], [@b0380]), poor sleep quality ([@b0070]), higher perceived stress load ([@b0275], [@b0070]), previous distressful lifeevents ([@b0270]), lack of psychological preparedness ([@b0070]), perceived self-efficacy to help the patients ([@b0070]), lacking knowledge of the pandemic ([@b0070], [@b0380]), not taking precautionary measures ([@b0380]), and impacts on daily life ([@b0450]). Furthermore relatives/friends/acquaintance suspected of/acquired COVID-19 ([@b0030], [@b0270], [@b0070], [@b0205], [@b0305], [@b0130]), less family support ([@b0070]), low social capital (during isolation) ([@b0400]), unsteady family income ([@b0030]), and higher social media exposure ([@b0100]) were associated with/increased the risk of depression and/or anxiety.

### 3.5.4. Job related factors {#s0090}

Working in frontline compared to second line ([@b0250], [@b0165]), secondary hospital compared to tertiary ([@b0165]), title intermediate compared to junior ([@b0165]), and \>10 years of working ([@b0165]) were associated with/increased the risk of depression and/or anxiety.

3.6. Risk factors of PTSS, psychological distress and affected general mental health {#s0095}
------------------------------------------------------------------------------------

The risk of PTSS were positively associated with female gender ([@b0345], [@b0240]), living in Hubei province ([@b0345], [@b0240]), lower education ([@b0240]) and subjective sleep quality ([@b0345], [@b0240]), but not with age ([@b0345]). A variety of factors was associated with higher psychological distress/affected general mental health ([@b0165], [@b0270], [@b0380], [@b0205], [@b0130], [@b0400], [@b0355], [@b0440], [@b0425], [@b0215], [@b0315], [@b0210]) and/or insomnia/poor sleep quality ([@b0430], [@b0165], [@b0070], [@b0400], [@b0215], [@b0370], [@b0410]).

4. Discussion {#s0100}
=============

A total of 43 studies were included. Only two studies investigated mental health issues in COVID-19 patients finding a high level of PTSS (96.2%) and significantly higher level of depressive symptoms (29.2%). Two studies reported symptoms on psychiatric patients, which appeared to have worsening in psychiatric symptomatology. Among health care workers depression/depressive symptoms, anxiety, psychological distress and poor sleep quality were increased. Regarding the general public one paper revealed lower psychological well-being (WHO-5) compared to before COVID-19, while a longitudinal study found no difference in anxiety, depression or stress symptoms early in the pandemic compared to after four weeks. A variety of factors were associated with higher risk of psychiatric symptoms and/or low psychological well-being of the general public including female gender, front-line health care workers, and poor self-rated health.

4.1. Psychiatric symptoms among COVID-19 patients {#s0105}
-------------------------------------------------

It is well known that surviving critical illness can induce PTSS ([@b0335]) and in line with this, levels of PTSS were found to be very high (96.2%) among patients during hospital admission with COVID-19 infection ([@b0015]), which is far higher than found in the general public (7%) ([@b0240]). The risk of depression was also found to be higher among patients with COVID-19 ([@b0435]). It is generally established that infections are associated with a higher risk of mood disorders ([@b0010]), and there seems to be a higher risk after severe infections ([@b0150]). This is in line with the findings from the SARS-CoV-1 epidemic revealing depressive symptoms among patients during the infection ([@b0040], [@b0050]). This higher risk could be due to the corona-virus affecting the brain directly or indirectly by inducing a massive cytokine response affecting the brain ([@b0360]).

Of notice is that among patients with prior SARS-CoV-1 infection a higher rate of depression/depressive symptoms was observed after 1 month ([@b0045], [@b0390]) and 1 year ([@b0190]). The SARS-CoV-1 spread to more than 26 countries affecting more than 8000 people ([@b0385]) and 774 died from the infection ([@b0255]), while COVID-19 has already spread to 185 countries affecting more than 4.238.703 people ([@b0060]) and we must expect a huge after-wave of patients surviving COVID-19 suffering from depression.

Regarding anxiety the evidence is still scarce, and this should be investigated further since anxiety symptoms were reported during ([@b0040]) and following ([@b0045], [@b0390]) SARS-CoV-1. Furthermore SARS-CoV-1 has been shown to induce affective psychosis at least during the acute phase of the illness ([@b0185]), but we found no papers addressing this matter yet for SARS-CoV-2. Severe infections and inflammatory processes can cause delirium with a broad variety of psychiatric symptoms and encephalopathy, which has been reported among SARS-CoV-2 positive patients, but the evidence is still scarce and the neurotropic potential of SARS-CoV-2 needs to be elucidated ([@b0160]).

4.2. COVID-19 pandemic and impact on psychiatric symptoms among psychiatric patients {#s0110}
------------------------------------------------------------------------------------

Worsening of the psychiatric symptoms among some patients with pre-existing psychiatric disorders, was reported ([@b0080], [@b0445]), and two case studies report on the COVID-19 pandemic being a part of the psychotic content of two non-infected patients admitted to the psychiatric word ([@b0090], [@b0325]). However, our systematic review reveals that knowledge on the COVID-19 impact on patients with preexisting psychiatric disorders is very scarce, and the knowledge of impact from earlier pandemics/epidemics on this group is also very limited.

4.3. COVID-19 pandemic and impact on psychiatric symptoms among health care workers {#s0115}
-----------------------------------------------------------------------------------

From previous studies of the SARS CoV-1 epidemic it is known that health care workers are at risk of anxiety and depressive symptoms, which the current studies indicate also is the case of COVID-19. Health care workers should be regarded as a highly exposed group with a higher risk of psychiatric symptoms during the COVID-19 pandemic, and risk factors are female gender and frontline workers among others.

4.4. COVID-19 pandemic and impact on mental health in the general public {#s0120}
------------------------------------------------------------------------

Currently data is scarce, but indicates that mental health is affected in the general public, when compared to before the outbreak ([@b0330]); however, the only longitudinal study (following 333 participants up) found no difference in depression, anxiety and stress in the period with many new cases compared to the period with many recovering ([@b0375]). This is interesting, since it is known from the prior SARS-CoV-1 epidemic that those in the general public, who were impacted of the epidemic (e.g. by quarantine) had psychiatric symptoms months after control of the epidemic ([@b0310]), and this could indicate that long lasting symptoms after SARS-CoV-2 also must be expected.

4.5. Risk factors of psychiatric symptoms in relation to the COVID-19 pandemic {#s0125}
------------------------------------------------------------------------------

Many risk factors (especially of depressive and anxiety symptoms) has been reported, but most of them are already well-known risk factors for mental health conditions (e.g. female gender ([@b0260]), current or past medical history ([@b0155]), and poor-self-related health ([@b0285]). However the pandemic is adding an aspect of quarantine and isolation that is also an established risk factor with psychological impact ([@b0020]), like worrying about family, friends and acquaintances being infected is also a newly added dimension. Due to the altered living conditions many of the identified risk factors will increase most likely leading to an increase in patients.

4.6. Potential biological mechanisms of SARS-CoV-2 and the effect on psychiatric symptoms {#s0130}
-----------------------------------------------------------------------------------------

There are indications in the literature of a neurotropic effect of SARS-CoV-2. Evidence of a variety of neurological symptoms among patients suffering from COVID-19 is evolving ([@b0265]), and delirium is a frequently reported symptom of SARS-CoV-2 and could be caused by a direct CNS invasion ([@b0160]). Interestingly two case studies reports SARS-CoV-2 meningitis/encephalitis ([@b0290], [@b0415]); however, only one of them had a confirmed positive SARS-CoV-2 RT-PCR test on CSF ([@b0290]). ACE2 is a functional receptor for SARS-CoV-2 ([@b0195]) and it is known that ACE2 is expressed in neurons ([@b0360]), which is interesting in the light of the many reports of anosmia as an early symptom of COVID-19 ([@b0180]), since SARS-CoV-1 has been suggested to enter the brain trough the olfactory bulb ([@b0300]). Taken together this indicates that SARS-CoV-2 could be neurotrophic entering the brain through the olfactory bulb, leading to an increase in neuropsychiatric symptoms among the patients surviving COVID-19.

When discussing the potential effects of SARS-CoV-2 on the brain it is worth noting the reports on altered peripheral immunological alterations among COVID-19 patients ([@b0360]). Significantly higher levels of neutrophils, but significantly lower levels of lymphocytes have been reported among severe cases compared to nonsevere ([@b0265]), and patients with SARS-CoV-2 have been reported to have high amounts of the pro-inflammatory cytokines (IL-1beta, IFN-gamma, IP10 and MCP-1) suggesting a Th1 response ([@b0120]). A pro-inflammatory response has been reported among patients with MDD in both plasma ([@b0145]) and CSF ([@b0075]), and the associations between neuropsychiatric symptoms and proinflammatory response needs to be elucidated further.

4.7. Strengths and limitations {#s0135}
------------------------------

The strength of this review is that it was systematically conducted. The study is limited by several factors. Firstly, the majority of the studies were conducted in Asia (only four studies from Europe and none from other continents), limiting the current generalization of the results. Secondly, most of the studies were not case-control studies no (35/43) and with a variety of reported outcomes, measuring of outcomes and statistical analysis was revealed. Thirdly, the literature on psychiatric symptoms among patients with SARS-CoV-2 infection and among psychiatric patients were very limited.

5. Conclusion and perspectives {#s0140}
==============================

Although the current evidence is scarce concerning direct effects of COVID-19 on mental health, there are indications of increased levels of PTSS and depression following the COVID-19 infection. Regarding the indirect effects of COVID-19 on general mental health there seems to be evidence of an increase in depressive and anxiety symptoms along with negative impact on general mental health, particularly among health care workers. Research evaluating the direct neuropsychiatric consequences and the indirect effects on mental health is highly needed to improve treatment, mental health care planning and for preventive measures during potential subsequent pandemics.
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[^1]: **Abbreviations:** PCL-C: self-reported PTSD Checklist (5 or 17 items), GHQ-9/12: 9/12-item General Health Questionnaire, GAD-7: 7-item Generalized Anxiety Disorder, SDS: Self-rating Depression Scale, SAS: Self-rating Anxiety Scale, CES-D: Center for Epidemiology Scale for Depression, PSQI: Pittsburgh Sleep Quality Index, ISI: Insomnia Severity Index, IES-R: 22-item Impact of Event Scale-Revised, VTS: Vicarious Traumatization Scale, NRS: numeric rating scale on fear, HAMA: Hamilton Anxiety Scale, HAMD: Hamilton Depression Scale, GSES: General Self-Efficacy Scale, SARS: Stanford Acute Stress Reaction, SSRS: Social Support Rate Scale, SF-36: 36-Item Short Form Survey, SCL-90-R: Symptom Check List-revised, PHQ-2/4/9: Patient Health Questionnaire-2/4/9 items.

[^2]: **Abbreviations:** PCL-C: self-reported PTSD Checklist (5 or 17 items), GHQ-9/12: 9/12-item General Health Questionnaire, GAD-7: 7-item Generalized Anxiety Disorder, SAS: Self-rating Anxiety Scale, PSQI: Pittsburgh Sleep Quality Index, ISI: Insomnia Severity Index, IES-R: 22-item Impact of Event Scale-Revised, SF-36: 36-Item Short Form Survey, SCL-90-R: Symptom Check List-revised, PHQ-2/4/9: Patient Health Questionnaire-2/4/9 items, BSCS: Brief Self-Control Scale, CPDI: COVID-19 Peritraumatic Distress Index, *K*10: Kessler 10 Psychological Distress Scale, TEMPS-A: Italian Temperament Evaluation of Memphis, Pisa, Paris and San Diego-Autoquestionnaire, ASQ: Attachment Style Questionnaire, PSCI-16: Personal Social Capital

[^3]: Scale 16, DASS-21: Depression, Anxiety and Stress Scale, SF12: Short Form 12, K6: six-item Kessler psychological distress scale, VDAS: Van Dream Anxiety Scale, SRQ-20: Self-Report Questionnaire (20-items), CD-RISC: Connor-Davidson resilience scale, SOS: Stress overload Scale, PSS: Perceived Stress Scale. BDI-II: Beck Depression Inventory-II, BAI: Beck anxiety inventory, AIS: Athen Insomina, Scale, PID-5-BF: Personality Inventory DSM-5-Brief-Form-Adult, HAI: Health Anxiety Inventory.
